HELIX ACQUISITION CORP's ticker is HLXA and the CUSIP is G4444C102. A total of 46 filers reported holding HELIX ACQUISITION CORP in Q4 2021. The put-call ratio across all filers is - and the average weighting 0.1%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q1 2022 | $6,285,000 | -14.9% | 566,191 | -24.2% | 0.00% | 0.0% |
| Q4 2021 | $7,386,000 | -1.1% | 746,862 | -1.2% | 0.00% | 0.0% |
| Q3 2021 | $7,465,000 | -4.5% | 756,303 | 0.0% | 0.00% | 0.0% |
| Q2 2021 | $7,813,000 | -3.7% | 756,303 | -4.5% | 0.00% | 0.0% |
| Q1 2021 | $8,109,000 | -5.0% | 792,285 | +0.6% | 0.00% | 0.0% |
| Q4 2020 | $8,532,000 | – | 787,785 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Foresite Capital Management V, LLC | 250,000 | $2,843,000 | 2.10% |
| Octagon Capital Advisors LP | 400,000 | $4,548,000 | 1.58% |
| SILVERARC CAPITAL MANAGEMENT, LLC | 215,071 | $2,445,000 | 1.42% |
| Ghost Tree Capital, LLC | 500,000 | $5,685,000 | 1.27% |
| Altium Capital Management LP | 250,000 | $2,843,000 | 1.06% |
| Logos Global Management LP | 200,000 | $2,274,000 | 0.20% |
| Bain Capital Life Sciences Investors, LLC | 250,000 | $2,843,000 | 0.18% |
| Consonance Capital Management LP | 150,000 | $1,685,000 | 0.16% |
| Avidity Partners Management LP | 400,000 | $4,548,000 | 0.15% |
| Boxer Capital, LLC | 400,000 | $4,548,000 | 0.15% |